drugset / Trial / NCT01997879
Study Assessing Ocular and Systemic Safety of AR-13324 in Healthy Volunteers
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess systemic safety and absorption of AR-13324 in healthy volunteers.
Timeline
- Start
- 2013-11
- Primary completion
- 2013-11
- Completion
- 2013-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Netarsudil | Small molecule | 0.02 % | Other |
Indications
No indication recorded.